Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10174028 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Patent 10174028 was granted and assigned to Array Biopharma Inc. on January, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Array Biopharma Inc.

Current Assignee

Array Biopharma Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Yutong Jiang0

Adam Golos0

Gabrielle R. Kolakowski0

Julia Haas0

Mark J. Chicarelli0

Steven W. Andrews0

James F. Blake0

Date of Patent

January 8, 2019

Patent Application Number

15860849

Date Filed

January 3, 2018

Patent Citations Received

US Patent 11964988 Fused heterocyclic compounds as RET kinase inhibitors

0

US Patent 10441581 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

0

US Patent 11524963 Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors

US Patent 10881652 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

US Patent 11603374 Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors

0

US Patent 11648243 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

0

US Patent 11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors

0

US Patent 11472802 Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors

Patent Primary Examiner

Patent abstract

Provided herein are compounds of the General Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10174028 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool